VOL 59, NO3 (2013)

Articles

287-287
Towards the Jubilee 10th International Conference on Breast Cancer "Petersburg White Nights"
https://doi.org/10.37469/0507-3758-2013-59-3-287-287
PDF (Russian) Неозаглавлен (Russian)
288-291
New approaches to the treatment of breast cancer
https://doi.org/10.37469/0507-3758-2013-59-3-288-291
PDF (Russian)
292-298
Endocrinology of breast cancer as a heterogeneous disease: a decade after the Millennium
https://doi.org/10.37469/0507-3758-2013-59-3-292-298
PDF (Russian)
299-301
Minimal breast cancer: some prognostic signs
https://doi.org/10.37469/0507-3758-2013-59-3-299-301
PDF (Russian)
302-313
The light desynchronization and the risk of cancer in humans: the state of the problem
https://doi.org/10.37469/0507-3758-2013-59-3-302-313
PDF (Russian)
314-319
Epidemiology and survival of breast cancer patients
https://doi.org/10.37469/0507-3758-2013-59-3-314-319
PDF (Russian)
320-327
Possibilities of surgical treatment for disseminated breast cancer
https://doi.org/10.37469/0507-3758-2013-59-3-320-327
PDF (Russian)
328-333
On the possibility of applying mammoscintigraphy to monitor the effectiveness of neoadjuvant polychemotherapy in breast cancer patients
https://doi.org/10.37469/0507-3758-2013-59-3-328-333
PDF (Russian)
334-340
Connection of metastasis-free survival in breast cancer patients and an expression vector of multidrug resistance genes in tumor during neoadjuvant chemotherapy
https://doi.org/10.37469/0507-3758-2013-59-3-334-340
PDF (Russian)
341-346
HER2-positive breast cancer: standard and double targeted treatment
https://doi.org/10.37469/0507-3758-2013-59-3-341-346
PDF (Russian)
347-351
Modern possibilities of targeted therapy in the treatment of breast cancer patients with overexpression of HER-2/neu and metastatic damage of the brain
https://doi.org/10.37469/0507-3758-2013-59-3-347-351
PDF (Russian)
352-357
Family diabetes and its consequences in cancer patients
https://doi.org/10.37469/0507-3758-2013-59-3-352-357
PDF (Russian)
358-362
Clinical and morphological features of breast cancer in men
https://doi.org/10.37469/0507-3758-2013-59-3-358-362
PDF (Russian)
363-368
Markers of effectiveness of preoperative taxane-chemotherapy for locally advanced breast cancer
https://doi.org/10.37469/0507-3758-2013-59-3-363-368
PDF (Russian)
369-374
Possibilities of remaxol in prevention of toxic hepatitis during chemotherapy for cancer patients
https://doi.org/10.37469/0507-3758-2013-59-3-369-374
PDF (Russian)
375-381
The effectiveness of ultrasound and sonoelastography in diagnostics of non-palpable and palpable breast lesions
https://doi.org/10.37469/0507-3758-2013-59-3-375-381
PDF (Russian)
382-385
Experience in the implementation of screening program for early detection of breast cancer in the Khanty-Mansi Autonomous Region - Yugra
https://doi.org/10.37469/0507-3758-2013-59-3-382-385
PDF (Russian)
386-389
Clinical and morphological features and treatment of lobular breast cancer
https://doi.org/10.37469/0507-3758-2013-59-3-386-389
PDF (Russian)
390-392
Immunological differences of triple-negative and luminal A breast cancer
https://doi.org/10.37469/0507-3758-2013-59-3-390-392
PDF (Russian)
393-396
Bilateral breast cancer (epidemiological aspects)
https://doi.org/10.37469/0507-3758-2013-59-3-393-396
PDF (Russian)
397-404
Role of ovarian suppression in complex treatment of breast cancer patients in premenopause
https://doi.org/10.37469/0507-3758-2013-59-3-397-404
PDF (Russian)